Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (41-50 of 188) with videos related to

Pageof 19
Sort By:
Environmental Health Perspectives|June 5, 2003
Childhood leukemia: electric and magnetic fields as possible risk factorsJoseph D Brain, Robert Kavet, David L McCormick, et al.
Science (New York, N.Y.)|October 9, 2004
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemiaAndrew P Weng, Adolfo A Ferrando, Woojoong Lee, et al.
British Journal of Haematology|October 4, 2005
Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemiasAihong Li, Meredith A Goldwasser, Jianbiao Zhou, et al.
American Journal of Clinical Pathology|June 14, 2015
Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series ReviewRyan C Johnson, Olga K Weinberg, Michael J Cascio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic LeukemiaPeter D Cole, Yaron Finkelstein, Kristen E Stevenson, et al.
Blood|October 6, 2011
ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemiaJulie Rousseau, Vincent Gagné, Malgorzata Labuda, et al.
Pharmacogenomics|May 7, 2020
HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI ConsortiumVincent Gagné, Pascal St-Onge, Patrick Beaulieu, et al.
Blood Advances|October 5, 2021
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium TrialsYannis K Valtis, Kristen E Stevenson, Andrew E Place, et al.
Pediatric Blood & Cancer|January 18, 2014
Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trialPaul V Plourde, Sima Jeha, Nobuko Hijiya, et al.
Blood|May 9, 2007
Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01Jianbiao Zhou, Meredith A Goldwasser, Aihong Li, et al.
Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
Environmental Health Perspectives|June 5, 2003
Childhood leukemia: electric and magnetic fields as possible risk factorsJoseph D Brain, Robert Kavet, David L McCormick, et al.
Science (New York, N.Y.)|October 9, 2004
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemiaAndrew P Weng, Adolfo A Ferrando, Woojoong Lee, et al.
British Journal of Haematology|October 4, 2005
Distinctive IGH gene segment usage and minimal residual disease detection in infant acute lymphoblastic leukaemiasAihong Li, Meredith A Goldwasser, Jianbiao Zhou, et al.
American Journal of Clinical Pathology|June 14, 2015
Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series ReviewRyan C Johnson, Olga K Weinberg, Michael J Cascio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Polymorphisms in Genes Related to Oxidative Stress Are Associated With Inferior Cognitive Function After Therapy for Childhood Acute Lymphoblastic LeukemiaPeter D Cole, Yaron Finkelstein, Kristen E Stevenson, et al.
Blood|October 6, 2011
ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemiaJulie Rousseau, Vincent Gagné, Malgorzata Labuda, et al.
Pharmacogenomics|May 7, 2020
HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI ConsortiumVincent Gagné, Pascal St-Onge, Patrick Beaulieu, et al.
Blood Advances|October 5, 2021
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium TrialsYannis K Valtis, Kristen E Stevenson, Andrew E Place, et al.
Pediatric Blood & Cancer|January 18, 2014
Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trialPaul V Plourde, Sima Jeha, Nobuko Hijiya, et al.
Blood|May 9, 2007
Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01Jianbiao Zhou, Meredith A Goldwasser, Aihong Li, et al.
Pageof 19